NYSE - Delayed Quote • USD
Koninklijke Philips N.V. (PHG)
At close: April 19 at 4:00 PM EDT
After hours: April 19 at 4:09 PM EDT
Earnings Estimate
CURRENCY IN USD | Current Qtr. (Mar 2024) | Next Qtr. (Jun 2024) | Current Year (2024) | Next Year (2025) |
---|---|---|---|---|
No. of Analysts | 1 | 1 | 8 | 8 |
Avg. Estimate | 0.28 | 0.33 | 1.43 | 1.68 |
Low Estimate | 0.28 | 0.33 | 0.87 | 1.2 |
High Estimate | 0.28 | 0.33 | 1.6 | 1.94 |
Year Ago EPS | -- | 0.3 | 1.33 | 1.43 |
Revenue Estimate
CURRENCY IN USD | Current Qtr. (Mar 2024) | Next Qtr. (Jun 2024) | Current Year (2024) | Next Year (2025) |
---|---|---|---|---|
No. of Analysts | 1 | 1 | 9 | 9 |
Avg. Estimate | 4.44B | 4.78B | 20B | 20.98B |
Low Estimate | 4.44B | 4.78B | 19.72B | 20.59B |
High Estimate | 4.44B | 4.78B | 20.76B | 21.83B |
Year Ago Sales | -- | -- | 19.34B | 20B |
Sales Growth (year/est) | -- | -- | 3.40% | 4.90% |
Earnings History
CURRENCY IN USD | 6/30/2023 | 9/30/2023 | 12/31/2023 | |
---|---|---|---|---|
EPS Est. | -- | 0.31 | 0.35 | 0.6 |
EPS Actual | -- | 0.3 | 0.36 | 0.44 |
Difference | -- | -0.01 | 0.01 | -0.16 |
Surprise % | -- | -3.20% | 2.90% | -26.70% |
EPS Trend
CURRENCY IN USD | Current Qtr. (Mar 2024) | Next Qtr. (Jun 2024) | Current Year (2024) | Next Year (2025) |
---|---|---|---|---|
Current Estimate | 0.28 | 0.33 | 1.43 | 1.68 |
7 Days Ago | 0.28 | 0.33 | 1.44 | 1.69 |
30 Days Ago | 0.3 | 0.34 | 1.49 | 1.76 |
60 Days Ago | 0.3 | 0.33 | 1.49 | 1.76 |
90 Days Ago | 0.34 | 0.37 | 1.63 | 1.91 |
EPS Revisions
CURRENCY IN USD | Current Qtr. (Mar 2024) | Next Qtr. (Jun 2024) | Current Year (2024) | Next Year (2025) |
---|---|---|---|---|
Up Last 7 Days | -- | -- | -- | -- |
Up Last 30 Days | -- | -- | -- | -- |
Down Last 7 Days | -- | -- | -- | -- |
Down Last 30 Days | -- | -- | -- | -- |
Growth Estimates
CURRENCY IN USD | PHG | Industry | Sector | S&P 500 |
---|---|---|---|---|
Current Qtr. | -- | -- | -- | 1.60% |
Next Qtr. | 10.00% | -- | -- | 10.50% |
Current Year | 7.50% | -- | -- | 5.20% |
Next Year | 17.50% | -- | -- | 13.30% |
Next 5 Years (per annum) | 16.56% | -- | -- | 11.22% |
Past 5 Years (per annum) | 11.31% | -- | -- | -- |
Research Analysis
Analyst Price Targets
Fair Value
Fair Value is the appropriate price for the shares of a company, based on its earnings and growth rate also interpreted as when P/E Ratio = Growth Rate. Estimated return represents the projected annual return you might expect after purchasing shares in the company and holding them over the default time horizon of 5 years, based on the EPS growth rate that we have projected.
Analyst Recommendations
Earnings
Upgrades & Downgrades
Downgrade | Societe Generale: Buy to Hold | 7/25/2022 |
Downgrade | Jefferies: Buy to Hold | 1/20/2022 |
Upgrade | HSBC: Hold to Buy | 1/14/2022 |
Downgrade | Citigroup: Buy to Neutral | 1/12/2022 |
Downgrade | Deutsche Bank: Buy to Hold | 7/8/2021 |
Upgrade | JP Morgan: Neutral to Overweight | 3/18/2021 |
Related Tickers
SNN Smith & Nephew plc
23.84
-0.71%
BSX Boston Scientific Corporation
67.33
-0.13%
NVRO Nevro Corp.
12.07
-2.03%
PODD Insulet Corporation
166.25
+0.92%
ATEC Alphatec Holdings, Inc.
12.54
+1.62%
STE STERIS plc
199.51
-0.65%
CNMD CONMED Corporation
72.64
+2.19%
AXNX Axonics, Inc.
66.95
-0.15%
ZBH Zimmer Biomet Holdings, Inc.
119.43
+0.08%
IART Integra LifeSciences Holdings Corporation
28.68
-9.33%